233 related articles for article (PubMed ID: 19280929)
1. [Pulmonary involvements in patients with collagen disease].
Endo H
Nihon Rinsho; 2009 Mar; 67(3):536-41. PubMed ID: 19280929
[TBL] [Abstract][Full Text] [Related]
2. [Collagen diseases with pulmonary involvement].
Kuwana M
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):118-26. PubMed ID: 15291248
[TBL] [Abstract][Full Text] [Related]
3. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
4. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
[TBL] [Abstract][Full Text] [Related]
5. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
Aoun NY; Velez E; Aggarwal A; Hayes GB; Kenney LA
Respir Care; 2004 Dec; 49(12):1515-21. PubMed ID: 15571643
[TBL] [Abstract][Full Text] [Related]
6. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
[TBL] [Abstract][Full Text] [Related]
7. [Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myeloperoxidase antibody(MPO-ANCA) without pathological renal involvement].
Yamada T; Nakajima H; Tanaka E; Nakajima A; Terai C; Hara M; Kamatani N
Ryumachi; 2003 Oct; 43(4):690-5. PubMed ID: 14598664
[TBL] [Abstract][Full Text] [Related]
8. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
10. [Pericarditis in collagen vascular disease].
Tamura N
Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():368-71. PubMed ID: 17948712
[No Abstract] [Full Text] [Related]
11. Interstitial lung diseases in collagen vascular diseases.
Lamblin C; Bergoin C; Saelens T; Wallaert B
Eur Respir J Suppl; 2001 Sep; 32():69s-80s. PubMed ID: 11816826
[TBL] [Abstract][Full Text] [Related]
12. [Organ lesions and progress in diagnosis of collagen diseases. 2) Pulmonary lesions].
Kitamura S
Nihon Naika Gakkai Zasshi; 1997 Aug; 86(8):1358-63. PubMed ID: 9410936
[No Abstract] [Full Text] [Related]
13. [Interstitial lung diseases in polymyositis and dermatomyositis].
Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
[TBL] [Abstract][Full Text] [Related]
14. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary involvement in polymyositis and dermatomyositis].
Tillie-Leblond I; Colin G; Lelong J; Cadranel J
Rev Mal Respir; 2006 Dec; 23(6):671-80. PubMed ID: 17202971
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma lung: pathogenesis, evaluation, and current therapy.
Co HT; Block JA; Sequeira W
Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases.
Lin Y; Zheng W; Tian X; Zhang X; Zhang F; Dong Y
J Clin Rheumatol; 2009 Oct; 15(7):341-4. PubMed ID: 20009969
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
Kurita T; Yasuda S; Amengual O; Atsumi T
Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
[TBL] [Abstract][Full Text] [Related]
20. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
